Name: the influence of liver resection on intrahepatic tumor growth
Uploaded: 2016-04-09T14:00:00.000+00:00
Duration: 7 min 55 s
Description: Watch this Scientific Journal Video about The Influence of Liver Resection on Intrahepatic Tumor Growth at JoVE.com

Special acknowledgements go to Dr. Benjamin Motsch for his assistance in technical questions. The authors would also like to acknowledge Dr. Marcus Forschner and Birk M&#252;ller for their multimedia support, Erica Magelky for her editorial expertise and Lisa Hornung, Dr. Roland Jurgons and Professor Stephan von H&#246;rsten (all from the Franz-Penzoldt-Center, University of Erlangen) for their professionalism in animal handling and care. We thank Professor Michael Neumaier at the Institute of Clinical Chemistry, Medical Faculty Mannheim of the University of Heidelberg, Germany for providing MC38 tumor cells.
The present work was performed in fulfillment of the requirements for obtaining the degree &#34;Dr. med.&#34; at the Friedrich-Alexander-University Erlangen-N&#252;rnberg (FAU).

The government of Middle Franconia in Bavaria, Germany, granted permission for the procedures described. Any similar experiments require prior authorization by the appropriate authorities.
Note: The following manual can be used for previously discussed groups A through C. Steps that have to be left out in groups A and B are marked accordingly.
1. Preparations
<ol>
	<li>Put on gloves, place the polystyrene pad underneath the microscope, and focus the lens on the area slightly above the pad.</li>
	<li>Split the sterile sheet and place half over the polystyrene pad and the other half just next to it.</li>
	<li>Sterilize the surgical instruments and place them on a sterile sheet next to the Polystyrene pad.</li>
	<li>Unbend a large paper clip to form an arch. Turn it upside down and press it into the polystyrene pad at the top end - just next to where the animal&#39;s head will lie.</li>
	<li>Place the mouthpiece of the vaporizer between the two limbs of the arch. (Figure 7)</li>
	<li>Set up a heating lamp about 40 cm from the place where the animal&#39;s head will lie. Make sure the heat at the level of the polystyrene pad does not exceed 40 &#176;C.</li>
	<li>Prepare a separate cage for operated animals.</li>
	<li>Prepare a defined quantity and volume (maximum of 50 &#181;l) of tumor cells in a flex tube and store it on ice.</li>
</ol>
2. Anesthesia
<ol>
	<li>Place the mouse into a plexiglas box and begin anesthetic induction on high flow isoflurane (5% isoflurane at a flow of 10 L/min).</li>
	<li>After going through the different stages of anesthesia, remove the mouse from the plexiglas box just after it has entered the stage of agonal breathing, which can easily be recognized by a drastic decrease in respiratory rate (&#60;20/min) and deep gasps shaking the animal&#39;s entire body.</li>
	<li>Quickly place the animal belly-up onto the sterile drape covered polystyrene pad and continue ventilation on low-flow isoflurane by inserting the mouse&#39;s snout into the mouthpiece to maintain anesthesia. Use an inspiratory fraction of 1.8-2.2% at a flow of about 1 L/min.</li>
	<li>Evaluate the depth of anesthesia during the operation by calculating the respiratory frequency, which is ideally between 45 and 60 breaths per min. Adapt the inspiratory isoflurane fraction accordingly if this is not the case. 
	Note: Changes in the inspiratory isoflurane fraction take about 60 sec until they become effective. Avoid carrying out drastic changes rapidly. Instead, modify the anesthetic&#39;s application gradually.</li>
</ol>
3. Operation
<ol>
	<li>Disinfect the chest and abdomen with an adequate disinfectant and change gloves afterwards.</li>
	<li>Inject a weight-adapted volume of carprofen (5 mg/kg bodyweight) into the animal&#39;s thigh.</li>
	<li>Gently pinch the abdominal skin with a forceps to test if the depth of anesthesia is adequate.</li>
	<li>Perform an incision along the median line from the xiphoid to the mid-abdomen using scissors and forceps.</li>
	<li>Carefully dissect the area around the xiphoid to expose it from the surrounding tissue.</li>
	<li>Place a stay suture through the xiphoid (from inside to outside) and attach both threads to the retainer above the animals head using the clamp.</li>
	<li>Pinch the retractor&#39;s limbs together and slowly introduce the &#34;U&#34;-shaped retractor tips along the animal&#39;s internal abdominal wall. 
	Note: These measures expose the liver to facilitate access to the different lobes. The identification of the liver&#39;s median and left lateral lobe should now be possible.</li>
	<li>Use a saline-soaked cotton swab and gently push the median lobe downwards. Dissect the ventral three quarters of the falciform ligament, which will now be visible between the median lobe&#39;s surface and the diaphragm.</li>
	<li>Now, use two saline-soaked cotton swabs to shift the median lobe and left lateral lobe upwards against the diaphragm.</li>
	<li>Visualize the thin membrane between the left lateral lobe and the caudate lobe and carefully dissect it. 
	Note: When performing this protocol on animals from group A, jump to step 3.18 at this point.</li>
	<li>Place a size 4-0 ligature diagonally along the left lateral lobe&#39;s base.</li>
	<li>Next, use the cotton swab to return the left lateral lobe to its original position.</li>
	<li>Carefully tie the ligature as close to the lobe&#39;s base as possible and assess for color change in the lobe to test for adequately interrupted blood supply.</li>
	<li>Resect the left lateral lobe by following the line of the lobe&#39;s base and note the resected lobe&#39;s weight. 
	Note: When performing this protocol on animals from group B, jump to step 3.18 at this point.</li>
	<li>Place a second ligature between the left lateral lobe&#39;s stump and the median lobe&#39;s base.</li>
	<li>Reposition the median lobe as well and tie the ligature. Again, assess for color change in the lobe to test for adequately interrupted blood supply.</li>
	<li>Resect the median lobe and note its weight.</li>
	<li>Connect the 1 ml syringe to the 30 G needle and fill it with the tumor cells from the flex tube without tilting the syringe at any time.</li>
	<li>Use the cotton swabs to move the intestinal loops to the animal&#39;s left in order to expose the inferior right lobe.</li>
	<li>Insert the cell-loaded syringe into the &#34;third-hand&#34; device at a 30&#176; angle to the vertical.</li>
	<li>Carefully move the device next to the mouse with the needle just above the inferior right lobe.</li>
	<li>Slowly advance the syringe within the third hand device until the needle&#39;s tip is in the inferior right lobe&#39;s center part.</li>
	<li>Inject the entire volume into the lobe&#39;s center part over a period of 30-45 sec.</li>
	<li>Compress the injection site for at least three minutes until bleeding has stopped.</li>
	<li>Remove the stay suture and the retractor.</li>
	<li>Close the fascia with a resorbable 5-0 suture using single button knots.</li>
	<li>Close the skin with a 4-0, non-resorbable suture using single button knots.</li>
	<li>Start ventilating the mouse on high flow oxygen for about 1 min.</li>
</ol>
4. Post-op procedure
<ol>
	<li>Place the animal into a warm environment (approximately 40 &#176;C) for the next half hour to ensure adequate recovery.</li>
	<li>Admix the animal&#39;s drinking water with 5 mg/ml of metamizole for 72 hr postoperative.</li>
	<li>Examine the integrity of the sutures closely for at least three days after the procedure.</li>
</ol>
5. Observation Period and Euthanasia
<ol>
	<li>Measure the animal&#39;s weight daily for a total of 14 days. Score them regarding their well-being and limitations respectively.</li>
	<li>After 14 days, anesthetize the animal following steps 2.1 and 2.2 of the operative protocol and proceed with institution&#39;s protocol for animal euthanasia.</li>
	<li>Perform a median laparotomy as explained in step 3.4. To facilitate access to the abdomen, extend the incision 1-1.5 cm caudally. Insert the retractor as pointed out in 3.7.</li>
	<li>Dissect along the rest of the falciform ligament and cut the inferior vena cava just as it exits the liver cranially.</li>
	<li>Separate the liver from the diaphragm, by grabbing the diaphragm with the forceps and bluntly dissecting into the space between liver and muscle tissue.</li>
	<li>Lift the mobilized liver tissue off the retroperitoneum and dissect it off the remaining structures it is still attached to: retroperitoneal fatty tissue, the inferior vena cava and the portal vein.</li>
	<li>Inspect the liver after extraction for any additional tissue, which would falsely contribute to its actual size and weight. An extracted liver and its tumor are displayed in Figure 6.</li>
	<li>Dissect the tumor off the inferior right lobe.</li>
	<li>Measure the size and weight of both the tumor and the liver parenchyma.</li>
	<li>Conserve additional tissue samples from the peritoneum, lymph nodes or other organs as needed for tissue analysis</li>
</ol>

<ol>
	<li>Haggar, F. A., Boushey, R. P. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Colorectal+cancer+epidemiology:+incidence,+mortality,+survival,+and+risk+factors.">Colorectal cancer epidemiology: incidence, mortality, survival, and risk factors.</a> Clin. Colon Rectal Surg. 22, 191-197 (2009).</li><li>Fong, Y., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Liver+resection+for+colorectal+metastases.">Liver resection for colorectal metastases.</a> J. Clin. Oncol. 15, 938-946 (1997).</li><li>Kato, T., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Therapeutic+results+for+hepatic+metastasis+of+colorectal+cancer+with+special+reference+to+effectiveness+of+hepatectomy:+analysis+of+prognostic+factors+for+763+cases+recorded+at+18+institutions.">Therapeutic results for hepatic metastasis of colorectal cancer with special reference to effectiveness of hepatectomy: analysis of prognostic factors for 763 cases recorded at 18 institutions.</a> Dis. Colon Rectum. 46, S22-S31 (2003).</li><li>Poston, G. J., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=OncoSurge:+a+strategy+for+improving+resectability+with+curative+intent+in+metastatic+colorectal+cancer.">OncoSurge: a strategy for improving resectability with curative intent in metastatic colorectal cancer.</a> J. Clin. Oncol. 23, 7125-7134 (2005).</li><li>Neumann, U. P., Seehofer, D., Neuhaus, P. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=The+surgical+treatment+of+hepatic+metastases+in+colorectal+carcinoma.">The surgical treatment of hepatic metastases in colorectal carcinoma.</a> Dtsch Arztebl Int. 107, 335-342 (2010).</li><li>Alwayn, I. P., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=A+critical+role+for+matrix+metalloproteinases+in+liver+regeneration.">A critical role for matrix metalloproteinases in liver regeneration.</a> J. Surg. Res. 145, 192-198 (2008).</li><li>Fausto, N., Campbell, J. S., Riehle, K. J. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Liver+regeneration.">Liver regeneration.</a> Hepatology. 43, S45-S53 (2006).</li><li>Fujiyoshi, M., Ozaki, M. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Molecular+mechanisms+of+liver+regeneration+and+protection+for+treatment+of+liver+dysfunction+and+diseases.">Molecular mechanisms of liver regeneration and protection for treatment of liver dysfunction and diseases.</a> J. Hepatobiliary. Pancreat. Surg. 18, 13-22 (2011).</li><li>Jin, X., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Paradoxical+effects+of+short-+and+long-term+interleukin-6+exposure+on+liver+injury+and+repair.">Paradoxical effects of short- and long-term interleukin-6 exposure on liver injury and repair.</a> Hepatology. 43, 474-484 (2006).</li><li>Nakamura, T., Sakai, K., Nakamura, T., Matsumoto, K. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Hepatocyte+growth+factor+twenty+years+on:+Much+more+than+a+growth+factor.">Hepatocyte growth factor twenty years on: Much more than a growth factor.</a> J. Gastroenterol. Hepatol. 26, 188-202 (2011).</li><li>Van Sweringen, H. L., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=CXC+chemokine+signaling+in+the+liver:+impact+on+repair+and+regeneration.">CXC chemokine signaling in the liver: impact on repair and regeneration.</a> Hepatology. 54, 1445-1453 (2011).</li><li>Heijboer, A. C., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Sixteen+hours+of+fasting+differentially+affects+hepatic+and+muscle+insulin+sensitivity+in+mice.">Sixteen hours of fasting differentially affects hepatic and muscle insulin sensitivity in mice.</a> J. Lipid Res. 46, 582-588 (2005).</li><li>Yang, S. Q., Lin, H. Z., Mandal, A. K., Huang, J., Diehl, A. M. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Disrupted+signaling+and+inhibited+regeneration+in+obese+mice+with+fatty+livers:+implications+for+nonalcoholic+fatty+liver+disease+pathophysiology.">Disrupted signaling and inhibited regeneration in obese mice with fatty livers: implications for nonalcoholic fatty liver disease pathophysiology.</a> Hepatology. 34, 694-706 (2001).</li><li>Selzner, M., Clavien, P. A. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Failure+of+regeneration+of+the+steatotic+rat+liver:+disruption+at+two+different+levels+in+the+regeneration+pathway.">Failure of regeneration of the steatotic rat liver: disruption at two different levels in the regeneration pathway.</a> Hepatology. 31, 35-42 (2000).</li><li>Matsuo, T., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Control+mechanism+of+the+circadian+clock+for+timing+of+cell+division+in+vivo.">Control mechanism of the circadian clock for timing of cell division in vivo.</a> Science. 302, 255-259 (2003).</li><li>Iakova, P., Awad, S. S., Timchenko, N. A. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Aging+reduces+proliferative+capacities+of+liver+by+switching+pathways+of+C/EBPalpha+growth+arrest.">Aging reduces proliferative capacities of liver by switching pathways of C/EBPalpha growth arrest.</a> Cell. 113, 495-506 (2003).</li><li>Pritchett-Corning, K. R., Luo, Y., Mulder, G. B., White, W. J. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Principles+of+rodent+surgery+for+the+new+surgeon.">Principles of rodent surgery for the new surgeon.</a> J Vis Exp. , (2011).</li><li>Skoulis, N. P., James, R. C., Harbison, R. D., Roberts, S. M. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Depression+of+hepatic+glutathione+by+opioid+analgesic+drugs+in+mice.">Depression of hepatic glutathione by opioid analgesic drugs in mice.</a> Toxicol. Appl. Pharmacol. 99, 139-147 (1989).</li><li>Berson, A., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Mechanisms+for+experimental+buprenorphine+hepatotoxicity:+major+role+of+mitochondrial+dysfunction+versus+metabolic+activation.">Mechanisms for experimental buprenorphine hepatotoxicity: major role of mitochondrial dysfunction versus metabolic activation.</a> J. Hepatol. 34, 261-269 (2001).</li><li>Baker, D. G. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Natural+pathogens+of+laboratory+mice,+rats,+and+rabbits+and+their+effects+on+research.">Natural pathogens of laboratory mice, rats, and rabbits and their effects on research.</a> Clin. Microbiol. Rev. 11, 231-266 (1998).</li><li>FELASA working group on revision of guidelines for health monitoring of rodents and rabbits. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=FELASA+recommendations+for+the+health+monitoring+of+mouse,+rat,+hamster,+guinea+pig+and+rabbit+colonies+in+breeding+and+experimental+units.">FELASA recommendations for the health monitoring of mouse, rat, hamster, guinea pig and rabbit colonies in breeding and experimental units.</a> Lab. Anim. 48, 178-192 (2014).</li><li>Nikfarjam, M., Malcontenti-Wilson, C., Fanartzis, M., Daruwalla, J., Christophi, C. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=A+model+of+partial+hepatectomy+in+mice.">A model of partial hepatectomy in mice.</a> J. Invest. Surg. 17, 291-294 (2004).</li><li>Hori, T., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Simple+and+reproducible+hepatectomy+in+the+mouse+using+the+clip+technique.">Simple and reproducible hepatectomy in the mouse using the clip technique.</a> World J. Gastroenterol. 18, 2767-2774 (2012).</li><li>Mitchell, C., Willenbring, H. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=A+reproducible+and+well-tolerated+method+for+2/3+partial+hepatectomy+in+mice.">A reproducible and well-tolerated method for 2/3 partial hepatectomy in mice.</a> Nat. Protoc. 3, 1167-1170 (2008).</li><li>Sowa, J. P., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Extent+of+liver+resection+modulates+the+activation+of+transcription+factors+and+the+production+of+cytokines+involved+in+liver+regeneration.">Extent of liver resection modulates the activation of transcription factors and the production of cytokines involved in liver regeneration.</a> World J. Gastroenterol. 14, 7093-7100 (2008).</li><li>Bonninghoff, R., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Effect+of+different+liver+resection+methods+on+liver+damage+and+regeneration+factors+VEGF+and+FGF-2+in+mice.">Effect of different liver resection methods on liver damage and regeneration factors VEGF and FGF-2 in mice.</a> Can. J. Surg. 55, 389-393 (2012).</li></ol>

The authors have nothing to disclose.

Previous experiments performing surgery in rodents have been able to identify certain variables that could serve as sources for bias. In order to obtain reliable and valid results, consider the following precautions.
Routine pre-op fasting can lead to liver steatosis12, which may inhibit liver regeneration13,14. It is therefore not recommended. The highest mitotic activity of hepatocytes varies throughout the day15. If possible, conduct the procedures at a cert...

Colorectal cancer (CRC) accounts for nearly 9% of all malignant tumors. It is the third most common cancer, both in the U.S. and worldwide. Global mortality rates from CRC range from 300,000 to over 500,000 per year1. Twenty percent of patients suffer from liver metastases upon discovery of their colorectal tumor. Resectable metastases are normally treated by a partial liver resection2,3. Improved surgical techniques, new multimodal strategies and new definitions of resectable metastases render the therapy of a partial liver resection possible for an increasing number of patients4.
Recurrence of secondary liver malignancies, however, is a challenging clinical sequalae in modern gastrointestinal surgery. Patients with CRC who underwent resection of liver metastases have a 30 to 50% chance of developing a new tumor in their remnant liver5. Therefore, there is a need for further research on the mechanisms involved in recurrence of liver metastases.
A liver resection of about 70% is normally compensated within a few weeks by the remaining hepatic tissue. This regeneration involves multiple mechanisms, including cytokines like Interleukin 6 (IL-6), tumor necrosis factor alpha (TNF-&#945;), hepatocyte growth factor (HGF), transforming growth factor beta (TGF-&#946;), vascular endothelial growth factor (VEGF), matrix metalloproteases (MMP-2 and MMP-9) and CXC-Chemokines6-11. These substances support hepatic regeneration and may also be responsible for the high recurrence rates of primary and secondary liver malignancies by inducing the growth of small tumor cell deposits in the remaining liver which are not detected by routine clinical imaging. This causality has not been proven so far.
The following hypothesis was established. After partial liver resection, the proliferation factors that are responsible for liver hypertrophy may also induce the growth of previously undiscovered tumor cells in the liver. A mouse model was designed which combined the techniques of liver resection and tumor induction. Thirty athymic nude-foxn1nu/nu mice were divided into three groups of ten animals each. Each of them was treated with either a laparotomy alone (Group A), a 30% liver resection (Group B) or a 70% liver resection (Group C). Animals in all groups subsequently received a tumor cell injection into a defined remaining part of the liver, to simulate dormant tumor cells. Animals where observed for two weeks and then evaluated for tumor growth and liver hypertrophy.
The objective was to create a model that could be used to search for the molecular and pathogenetic factors that may play a role in post-hepatectomy tumor formation. This method may be helpful in assessing: the origin of endocrine factors involved in liver regeneration; the responsible mechanisms for intrahepatic tumor growth after liver resection; and the liver resection volume necessary for intrahepatic tumor growth induction. The following method has only been performed on animals because they promise to contribute to the understanding of fundamental biological principles and to the development of knowledge that can be expected to benefit humans by improved treatment options. Due to the mechanisms involved in these matters, it had to be examined in vivo, as in vitro methods may not provide a realistic representation of the human pathology.
These investigations may lead to the discovery of relevant targets for prophylactic treatment options for decreasing tumor recurrence.

<table><tbody><tr><td>&lt;strong&gt;Equipment&lt;/strong&gt;</td><td></td><td></td><td></td></tr><tr><td>Operation Microscope</td><td>Zeiss</td><td>OPMI-1 FC S21</td><td></td></tr><tr><td>Induction Cage (Plexiglas Box)</td><td>UNO BV, Netherlands</td><td>180000132</td><td></td></tr><tr><td>Flowmeter + Connection Kit</td><td>UNO BV, Netherlands</td><td>180000008</td><td></td></tr><tr><td>UNO Vaporizer Sigma Delta</td><td>UNO BV, Netherlands</td><td>180000002</td><td></td></tr><tr><td>Key Filler for Anesthetic</td><td>UNO BV, Netherlands</td><td>180000010</td><td></td></tr><tr><td>Activated Charcoal Filter Adsorber</td><td>UNO BV, Netherlands</td><td>180000140</td><td></td></tr><tr><td>Gas Exhaust Unit</td><td>UNO BV, Netherlands</td><td>180000118</td><td></td></tr><tr><td>Face Mask for mouse</td><td>UNO BV, Netherlands</td><td>180000065</td><td></td></tr><tr><td>Vaporizer Stand</td><td>UNO BV, Netherlands</td><td>180000006</td><td></td></tr><tr><td>Heat lamp</td><td>Physitemp Instruments</td><td>HL-1</td><td></td></tr><tr><td>Styrofoam Pad</td><td>RAYHER</td><td>30074000&amp;nbsp;</td><td></td></tr><tr><td>Third Hand Tool</td><td>TOOLCRAFT&amp;nbsp;</td><td>ZD-10F</td><td></td></tr><tr><td>Precision Scales</td><td>Kern</td><td>EW 220-3NM</td><td></td></tr><tr><td>Scales&amp;nbsp;</td><td>Kern</td><td>EMB 500-1</td><td></td></tr><tr><td>Sliding Caliper</td><td>MIB</td><td>MIB 82026100</td><td></td></tr><tr><td>Microdissection forceps</td><td>Braun/Aesculap</td><td>BD195R</td><td></td></tr><tr><td>Microdissection scissors</td><td>Braun/Aesculap</td><td>FD100R</td><td></td></tr><tr><td>Microdissection needle holder</td><td>Braun/Aesculap</td><td>BM563R</td><td></td></tr><tr><td>Retractor</td><td>Fine Science Tools (F.S.T.)</td><td>No. 17001-0</td><td>Type: Bowmann</td></tr><tr><td>Clamp</td><td>Braun/Aesculap</td><td>BJ002R</td><td></td></tr><tr><td>&lt;strong&gt;Name&lt;/strong&gt;</td><td>&lt;strong&gt;Company&lt;/strong&gt;</td><td>&lt;strong&gt;Catalog Number&lt;/strong&gt;</td><td>&lt;strong&gt;Comments&lt;/strong&gt;</td></tr><tr><td>&lt;strong&gt;Expendable Items&lt;/strong&gt;&lt;br/&gt;(NOTE: Quantities are per animal and procedure)</td><td></td><td></td><td></td></tr><tr><td>Foliodrape sterile cover (45 cm x 75 cm)</td><td>Hartmann</td><td>2775001</td><td></td></tr><tr><td>Sterile Cotton Swabs (2x)</td><td>Hartmann</td><td>4700151</td><td>Peha</td></tr><tr><td>Sterile fluid (0.9% NaCl)</td><td>Braun</td><td>3570310</td><td>PZN=04454809</td></tr><tr><td>Disinfectant (Softasept - 250 ml)</td><td>Braun</td><td>3887138</td><td>PZN=0762008808505018</td></tr><tr><td>2 x 1 ml syringe (Injekt-F )</td><td>Braun</td><td>9166017V</td><td></td></tr><tr><td>26 G canula (Sterican) - for Carprofen injection</td><td>Braun</td><td>4665457</td><td></td></tr><tr><td>30 G canula (Sterican)&amp;nbsp; - for Tumor injection</td><td>Braun</td><td>4656300</td><td></td></tr><tr><td>Caprofen (=Rimadyl)</td><td>Pfizer</td><td>QM01AE91</td><td></td></tr><tr><td>Metamizole (= Novaminsulfon)</td><td>Ratiopharm</td><td>16543.00.00</td><td></td></tr><tr><td>4-0 Vicryl suture</td><td>Ethicon</td><td>J835G</td><td></td></tr><tr><td>5-0 Prolene suture</td><td>Ethicon</td><td>8618G</td><td></td></tr><tr><td>SafeLock Flex-Tube 1.5 ml</td><td>Eppendorf&amp;nbsp;</td><td>22363778</td><td></td></tr><tr><td>4 x 4 Gauze Sponge</td><td>Kendall/Covidien&amp;nbsp;</td><td>UPC: 728795135355&amp;nbsp;</td><td>ASIN: B005BFQTWM&amp;nbsp;</td></tr><tr><td>Large paperclip</td><td>ACCO</td><td>A7072510G</td><td></td></tr><tr><td>&lt;strong&gt;Name&lt;/strong&gt;</td><td>&lt;strong&gt;Company&lt;/strong&gt;</td><td>&lt;strong&gt;Catalog Number&lt;/strong&gt;</td><td>&lt;strong&gt;Comments&lt;/strong&gt;</td></tr><tr><td>&lt;strong&gt;Animals&lt;/strong&gt;</td><td></td><td></td><td></td></tr><tr><td>Female athymic nude-foxn1nu/nu</td><td>Harlan Laboratories B.V.</td><td>Code 069</td><td></td></tr></tbody></table>

the influence of liver resection on intrahepatic tumor growth

The high incidence of tumor recurrence after resection of metastatic liver lesions remains an unsolved problem. Small tumor cell deposits, which are not detectable by routine clinical imaging, may be stimulated by hepatic regeneration factors after liver resection. It is not entirely clear, however, which factors are crucial for tumor recurrence.
The presented mouse model may be useful to explore the mechanisms that play a role in the development of recurrent malignant lesions after liver resection. The model combines the easy-to-perform and reproducible techniques of defined amounts of liver tissue removal and tumor induction (by injection) in mice. The animals were treated with either a single laparotomy, a 30% liver resection, or a 70% liver resection. All animals subsequently received a tumor cell injection into the remaining liver tissue. After two weeks of observation, the livers and tumors were evaluated for size and weight and examined by immunohistochemistry.
After a 70% liver resection, the tumor volume and weight were significantly increased compared to a laparotomy alone (p &#60;0.05). In addition, immunohistochemistry (Ki67) showed an increased tumor proliferation rate in the resection group (p &#60;0.05).
These findings demonstrate the influence of hepatic regeneration mechanisms on intrahepatic tumor growth. Combined with methods like histological workup or RNA analysis, the described mouse model could serve as foundation for a close examination of different factors involved in tumor growth and metastatic disease recurrence within the liver. A considerable number of variables like the length of postoperative observation, the cell line used for injection or the timing of injection and liver resection offer multiple angles when exploring a specific question in the context of post-hepatectomy metastases. The limitations of this procedure are the authorization to perform the procedure on animals, access to an appropriate animal testing facility and acquisition of certain equipment.

In our specific experiment, we included 30 athymic nude-foxn1nu/nu mice. They received a median laparotomy, tumor cell injections of 500,000 MC38 tumor cells (dissolved in 50 &#181;l of saline), and were subsequently treated with either a 70% liver resection, a 30% liver resection, or no further intervention.
After 14 days, almost complete regeneration of the remaining liver following 30% or 70% liver resections (liver hypertrop...

Watch this Scientific Journal Video about The Influence of Liver Resection on Intrahepatic Tumor Growth at JoVE.com

The Influence of Liver Resection on Intrahepatic Tumor Growth

A high incidence of tumor recurrence after resection of liver metastases remains an unsolved problem. The illustrated mouse model may be useful to investigate the reasons for such recurrences. It combines a liver resection model with intrahepatic tumor cell injection for the first time.

The high incidence of tumor recurrence after resection of metastatic liver lesions remains an unsolved problem. Small tumor cell deposits, which are not ...

the-influence-of-liver-resection-on-intrahepatic-tumor-growth

Research

JoVE Journal

Medicine

9.4K Views.  Friedrich-Alexander-University Erlangen-Nürnberg (FAU). A high incidence of tumor recurrence after resection of liver metastases remains an unsolved problem. The illustrated mouse model may be useful to investigate the reasons for such recurrences. It combines a liver resection model with intrahepatic tumor cell injection for the first time. 

Video: The Influence of Liver Resection on Intrahepatic Tumor Growth

Murine Model of Metastatic Liver Tumors in the Setting of Ischemia Reperfusion Injury

Liver ischemia and reperfusion (I/R) injury, a common clinical challenge, remains an inevitable pathophysiological process that has been shown to induce multiple tissue and organ damage. Despite recent advances and therapeutic approaches, the overall morbidity has remained unsatisfactory especially in patients with underlying parenchymal abnormalities. In the context of aggressive cancer growth and metastasis, surgical I/R is suspected to be the promoter regulating tumor recurrence. This article aims to describe a clinically relevant murine model of liver I/R and colorectal liver metastasis. In doing so, we aim to assist other investigators in establishing and perfecting this model for their routine research practice to better understand the effects of liver I/R on promoting liver metastases.

We describe in detail a clinically relevant colorectal cancer liver metastases (CRLM) tumor model and the influence of liver ischemia reperfusion (I/R) in tumor growth and metastasis. This model can help to better understand the mechanisms underlying surgery-induced promotion of liver metastatic growth.

Liver ischemia and reperfusion (I/R) injury, a common clinical challenge, remains an inevitable pathophysiological process that has been shown to induce ...

Cancer Research

Application of Hemostatic Devices in Laparoscopic Hepatectomy

Laparoscopic hepatectomy is considered a conventional method for treating benign and malignant liver diseases because it is a minimally invasive method. Despite its non-invasive aspect, bleeding and bile leakage occur in liver parenchyma tissue resection during the operation or in the post-operation period, indicating the requirement for high-grade hemostatic devices, such as ultrasonic surgical aspiration, bipolar electrocoagulation, etc. The lack of availability of these high-grade hemostatic devices prevents laparoscopic hepatectomy from becoming a generalized procedure in basic medical organizations. In view of the situation mentioned above, a suite of simple and easy hemostatic devices is developed in this protocol, which includes a harmonic scalpel, monopole electrocoagulation, and a single lumen catheter, to innovatively perform liver parenchyma tissue resection. First of all, the porta hepatis or hepatic pedicle is occluded intermittently by a single lumen catheter, followed by clamping for 15 min and releasing for 5 min. Subsequently, using the harmonic scalpel, clamping and crushing of the liver are done to cut off the hepatic parenchyma tissue and to reveal the intrahepatic arteries, veins, and bile ducts. Lastly, the bleeding spots are coagulated by using monopole electrocoagulation at each spot. Intrahepatic pipeline structures are then visible by using these methods, which could stop bleeding easily, reduce the incidence rate of bile leakage, and improve the safety and feasibility of laparoscopic hepatectomy. Therefore, the simple and easy hemostatic devices shown here are suitable for conducting procedures in primary medical institutions.

High-grade hemostatic devices are essential for laparoscopic hepatectomy. However, these devices are not generalized in basic medical organizations. Therefore, a suite of simple and easy hemostatic devices is shown in this article, which can make the laparoscopic hepatectomy easier to perform.

Laparoscopic hepatectomy is considered a conventional method for treating benign and malignant liver diseases because it is a minimally invasive method. ...

Application of the En Bloc Concept Combined with Anatomic Resection in Laparoscopic Hepatectomy

Laparoscopic hepatectomy has been reported in many studies, and it is the mainstream method of liver resection. In some particular cases, such as when there are tumors adjacent to the cystic bed, surgeons cannot palpate the surgical margins through the laparoscopic approach, which leads to uncertainty about R0 resection. Conventionally, the gallbladder is resected first, and the hepatic lobes or segments are resected second. However, tumor tissues can be disseminated in the above cases. To address this issue, based on the recognition of the porta hepatis and intrahepatic anatomy, we propose a unique approach to hepatectomy combined with gallbladder resection by en bloc anatomic resection in situ. Firstly, after dissecting the cystic duct, without cutting the gallbladder primarily, the porta hepatis is pre-occluded by the single lumen ureter; secondly, the left hepatic pedicle is made free by the gap of the Laennec membrane and Hilar plate; thirdly, the assistant is asked to drag the fundus of the gallbladder, and the liver parenchyma tissue is resected using a harmonic scalpel along the ischemia line on the liver surface and intraoperative ultrasound. The whole middle hepatic vein (MHV) and its tributaries appear completely; lastly, the left hepatic vein (LHV) is disconnected, and the specimen is taken out from the abdominal cavity. The tumor, gallbladder, and other surrounding tissues are resected en bloc, which meets the tumor-free criterion, and a wide incisal margin and R0 resection are achieved. Therefore, the laparoscopic hepatectomy with the combination of the en bloc concept and anatomic resection is a safe, effective, and radical method with low postoperative recurrence and metastasis.

Numerous studies have demonstrated the advantages of anatomic resection. Nonetheless, whether anatomic resection can increase R0 resection rates remains controversial. Consequently, the present study describes an innovative procedure involving the en bloc concept combined with anatomic resection in laparoscopic hepatectomy, which can reduce postoperative recurrence and metastasis.

Laparoscopic hepatectomy has been reported in many studies, and it is the mainstream method of liver resection. In some particular cases, such as when ...

Patient&#45;Derived Hepatocarcinoma Cell Organoids for Liver Regeneration Study

A Hepatocellular Cancer Patient&#45;Derived Organoid Xenograft Model to Investigate Impact of Liver Regeneration on Tumor Growth

Recurrence poses a notable challenge after hepatocellular carcinoma (HCC) treatment, impacting more than 70% of patients who undergo surgical resection. Recurrence stems from undetected micro-metastasis or de novo cancer, potentially triggered by postsurgical liver regeneration. Prior research employed HCC cell lines in orthotopic models to study the impact of liver regeneration, but their limited validity prompted the need for a more representative model. Here, we introduce a novel approach utilizing patient-derived HCC organoids to investigate the influence of liver regeneration on HCC.
Patient tumor tissues are processed to create tumor organoids, embedded in a three-dimensional basement membrane matrix, and cultured in a liver-specific medium. One million organoids are injected into the right superior lobe (RSL) of immunodeficient mice, confirming macroscopic tumor growth through sonography. The intervention group undergoes resection of the left lateral lobe (LLL) (30% of total liver volume) or additionally, the middle lobe (ML) (65% of total liver volume) to induce liver regeneration within the tumor site. The control group experiences re-laparotomy without liver tissue resection. After 2 weeks, both groups undergo tumor and normal tissue explantation.
In conclusion, this patient-derived HCC organoid model offers a robust platform to investigate the impact of liver regeneration post-cancer resection. Its multi-cellular composition, genetic diversity, and prolonged culture capabilities make it an invaluable tool for studying HCC recurrence mechanisms and potential interventions.

Organoids generated from patient tumors are orthotopically injected into the mouse liver. The resection of non-tumorous liver tissue leads to a regenerative environment in the liver tissue where the tumor is located.

Recurrence poses a notable challenge after hepatocellular carcinoma (HCC) treatment, impacting more than 70% of patients who undergo surgical resection. ...

Laparoscopic Anterior Right Hepatectomy: A Single-Center Experience

Laparoscopic anterior right hepatectomy (LARH) has been used in some hospitals. However, data on the feasibility and safety of this procedure are still limited, due to the demanding technical requirements. The primary objective of this study was to compare the clinical outcomes of LARH with those of laparoscopic conventional right hepatectomy (LCRH) in patients with large right hepatocellular carcinoma, as well as to confirm the safety and feasibility of LARH. Furthermore, the article presents a step-by-step description of the surgical procedures for LARH to help perform this surgery in the clinic. The principle of LARH is to first prioritize the hepatic inlet duct separation while separating the right hepatic perihepatic ligament after transecting the liver. From December 2015 to June 2022, 82 patients with large right hepatocellular carcinoma (maximum tumor diameter &#8805; 5 cm), were recruited for the study. In this cohort, 54 and 28 patients underwent LARH and LCRH, respectively. The perioperative clinical data and survival outcomes of the two groups were compared. Compared with LCRH, LARH exhibited the advantages of less contact and extrusion, thereby leading to the achievement of superior results. Thus, we propose that LARH is the optimal choice for patients with large right hepatocellular carcinoma.

Here we present a step-by-step protocol for conducting laparoscopic anterior right hepatectomy and compare its clinical effects and postoperative outcomes with those of conventional hepatectomies. Analysis of the data of 82 patients with hepatocellular carcinoma revealed that laparoscopic anterior right hepatectomy had better clinical outcomes and survival rates than the conventional hepatectomy.

Laparoscopic anterior right hepatectomy (LARH) has been used in some hospitals. However, data on the feasibility and safety of this procedure are still ...

Behavior

Rat Model of the Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy (ALPPS) Procedure

Recent clinical data support an aggressive surgical approach to both primary and metastatic liver tumors. For some indications, like colorectal liver metastases, the amount of liver tissue left behind after liver resection has become the main limiting factor of resectability of large or multiple liver tumors. A minimal amount of functional tissue is required to avoid the severe complication of post-hepatectomy liver failure, which has high morbidity and mortality. Inducing liver growth of the prospective remnant prior to resection has become more established in liver surgery, either in the form of portal vein embolization by interventional radiologists or in the form of portal vein ligation several weeks prior to resection. Recently, it was shown that liver regeneration is more extensive and rapid, when the parenchymal transection is added to portal vein ligation in a first stage and then, after only one week of waiting, resection performed in a second stage (Associating Liver Partition and Portal vein ligation for Staged hepatectomy = ALPPS). ALPPS has rapidly become popular across the world, but has been criticized for its high perioperative mortality. The mechanism of accelerated and extensive growth induced by this procedure has not been well understood. Animal models have been developed to explore both the physiological and molecular mechanisms of accelerated liver regeneration in ALPPS. This protocol presents a rat model that allows mechanistic exploration of accelerated regeneration.

Rat Model of the Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy ALPPS Procedure

Inducing rapid liver hypertrophy using Associating Liver Partition and Portal vein ligation for a Staged hepatectomy (ALPPS) has been proposed for resection of borderline resectable liver tumors. This model may elucidate mechanisms involved in rapid hypertrophy and allows testing of drugs that promote or block the acceleration of regeneration.

Recent clinical data support an aggressive surgical approach to both primary and metastatic liver tumors. For some indications, like colorectal liver ...

Application of Laparoscopic Hepatectomy Combined with Intraoperative Microwave Ablation in Colorectal Cancer Liver Metastasis

Laparoscopic hepatectomy is a common treatment for colorectal cancer liver metastasis. Previously, a sufficient number of functional liver masses had to be maintained during laparoscopic hepatectomy, with a residual liver volume of &gt;40% in cirrhotic patients and &gt;30% in non-cirrhotic patients. The high incidence of complications such as bleeding, bile leakage, or liver failure due to the exposure and difficulty of the resection of specific liver segments such as S2 and S7 reduces the success rate of liver resection. At present, microwave ablation is mainly applied in the treatment of liver metastasis using a percutaneous approach, which makes it difficult to identify hidden parts or small lesions. For some liver segments, the percutaneous puncture of liver segment 7 (S7) is likely to pass through the thoracic cavity, and the percutaneous puncture of liver segment 2 (S2) adjacent to the diaphragm is likely to injure the diaphragm and heart; these issues restrict the application of percutaneous ablation in colorectal cancer liver metastasis. Considering multiple lesions, laparoscopic microwave ablation combined with hepatectomy was performed in this study. The location of the lesions was determined by contrast-enhanced ultrasound under laparoscopy, and small lesions that were difficult to detect before the operation were identified. For the scattered lesions, which had diameters less than 3 cm and were difficult to resect, ablation was adopted to substitute hepatectomy. This technique helped to more explicitly locate the tumors, simplified the operation procedures, reduced the risk of complications such as bleeding and bile leakage, shortened the operation time, accelerated the postoperative recovery, significantly improved the success rate of operation, and enhanced the clinical prognosis of colorectal cancer liver metastasis by surgical resection.

This protocol describes the laparoscopic resection of colorectal cancer liver metastases combined with ultrasound-guided microwave ablation. This technique can safely, effectively, and accurately treat refractory liver metastases &lt;3 cm, reduce postoperative complications, and accelerate the postoperative rehabilitation of patients.

Laparoscopic hepatectomy is a common treatment for colorectal cancer liver metastasis. Previously, a sufficient number of functional liver masses had to ...

Y-90 TARE and PD-1 Inhibition as Bridging Therapy in Hepatocellular Carcinoma

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

This study showcases a comprehensive treatment protocol for high-risk hepatocellular carcinoma (HCC) patients, focusing on the combined use of Y-90 transarterial radioembolization (TARE) and Programmed Cell Death-1 (PD-1) inhibitors as neoadjuvant therapy. Highlighted through a case report, it offers a step-by-step reference for similar therapeutic interventions. A retrospective analysis was conducted on a patient who underwent hepatectomy following Y-90 TARE and PD-1 inhibitor treatment. Key demographic and clinical details were recorded at admission to guide therapy selection. Y-90 TARE suitability and dosage calculation were based on Technetium-99m (Tc-99m) macroaggregated albumin (MAA) perfusion mapping tests. Lesion coverage by Y-90 microspheres was confirmed through single photon emission computed tomography/computed tomography (SPECT/CT) fusion imaging, and adverse reactions and follow-up outcomes were meticulously documented. The patient, with a 7.2 cm HCC in the right hepatic lobe (T1bN0M0, BCLC A, CNLC Ib) and an initial alpha-fetoprotein (AFP) level of 66,840 ng/mL, opted for Y-90 TARE due to high recurrence risk and initial surgery refusal. The therapy's parameters, including the lung shunting fraction (LSF) and non-tumor ratio (TNR), were within therapeutic limits. A total of 1.36 GBq Y-90 was administered. At 1 month post-therapy, the tumor shrank to 6 cm with partial necrosis, and AFP levels dropped to 21,155 ng/mL, remaining stable for 3 months. After 3 months, PD-1 inhibitor treatment led to further tumor reduction to 4 cm and AFP decrease to 1.84 ng/mL. The patient then underwent hepatectomy; histopathology confirmed complete tumor necrosis. At 12 months post-surgery, no tumor recurrence or metastasis was observed in follow-up sessions. This protocol demonstrates the effective combination of Y-90 TARE and PD-1 inhibitor as a bridging strategy to surgery for HCC patients at high recurrence risk, providing a practical guide for implementing this approach.

This study illustrates the methodological potential of combining Yttrium-90 Trans-Arterial Radioembolization (Y-90 TARE) with an anti-PD-1 monoclonal antibody as an effective neoadjuvant strategy leading to hepatectomy in hepatocellular carcinoma (HCC) patients with a high initial recurrence risk. It emphasizes the safety, feasibility, and step-by-step procedural guidance of this approach.

This study showcases a comprehensive treatment protocol for high-risk hepatocellular carcinoma (HCC) patients, focusing on the combined use of Y-90 ...

Laparoscopic Left Approach Resection of the Caudate Lobe

Laparoscopic caudate lobectomy (LCL) is one of the most challenging types of laparoscopic liver resections. The main difficulty lies in the deep anatomical position of the caudate lobe, which is closely adjacent to the first and second hepatic ports and the inferior vena cava, increasing the risk of major bleeding during surgery. In addition to a thorough understanding of the anatomy of the caudate lobe tumor, comprehensive imaging assessment, and three-dimensional reconstruction, the flexible choice of surgical approach is also key to reducing surgical difficulty and improving safety. We perform laparoscopic caudate lobectomy using a left-sided approach, especially when the tumor is located in the area of the caudate lobe close to the inferior vena cava. This method avoids the step of splitting the liver substance to expose the field of view required by the traditional anterior approach, with the advantages of larger operating space and shorter operation time. At the same time, combined with preoperative three-dimensional reconstruction technology, we have significantly reduced the risk of damaging important blood vessels and increased the success rate of resection of tumors in the caudate lobe.

Here, we present a surgical protocol describing the laparoscopic resection of a tumor situated near the paracaval portion within the caudate lobe, utilizing a left-sided approach.

Laparoscopic caudate lobectomy (LCL) is one of the most challenging types of laparoscopic liver resections. The main difficulty lies in the deep ...

Peripheral Subtractive Dissection of Glissonean Pedicles in Minimally Invasive Anatomic Liver Resection for Right Posterior Lobe Tumors

Minimally invasive anatomic liver resection (MIALR) has recently garnered significant attention and has rapidly advanced in the field of hepatobiliary surgery. In particular, the dissection of the Glissonean pedicle, such as in Atsushi Sugioka's Gate Theory, represents a fundamental operative technique within MIALR. This technique is based on the anatomical structure of the Laennec capsule, thereby promoting and implementing MIALR in a scientifically rigorous manner. However, potential risks such as hemorrhage, ischemia-reperfusion injury (IRI), and tumor rupture may arise during MIALR in clinical practice, particularly when it is applied to tumors located in the right posterior hepatic lobe near the bifurcation of the Glissonean pedicles (excluding hilar cholangiocarcinoma). To address these challenges, this study introduces a unique surgical approach, termed peripheral subtractive dissection of the Glissonean pedicle (PSDGP), designed to mitigate these potential complications. During the PSDGP procedure in MIALR for liver tumors, the cystic plate approach is utilized to facilitate extrahepatic dissection. Initially, a non-absorbable suture is threaded from Gate VI to Gate IV under the guidance of non-traumatic forceps (or similar instruments). Subsequently, the non-traumatic forceps are passed through Gate V again to retrieve the non-absorbable suture from Gate IV. Finally, both Gate V and Gate VI are used to achieve the separation of the right posterior Glissonean pedicle. This method may improve surgical success rates and yield better oncological outcomes due to its strict adherence to the no-touch and en-bloc principles of tumor resection.

Minimally invasive anatomic liver resection (MIALR) involving Glissonean pedicle ligation for the right posterior hepatic lobe may cause tumor rupture, hemorrhage, and ischemia-reperfusion injury (IRI). This study proposes a novel surgical approach, peripheral subtractive dissection of the Glissonean pedicle (PSDGP), aimed at mitigating these risks.

Minimally invasive anatomic liver resection (MIALR) has recently garnered significant attention and has rapidly advanced in the field of hepatobiliary ...